Send the following on WhatsApp
Continue to Chathttps://www.zonebourse.com/cours/action/ZYDUS-LIFESCIENCES-LIMITE-34067618/actualite/Zydus-recoit-l-approbation-provisoire-de-l-USFDA-pour-l-Edaravone-Injection-30-mg-100-mL-0-3-mg-m-46221308/?utm_source=whatsapp&utm_medium=social&utm_campaign=share